Abstract
Summary
A systematic review and meta-analysis was conducted on the prevalence of osteoporosis in the Eastern Mediterranean Region. The overall pooled prevalence of osteoporosis was 24.4%. The prevalence has increased significantly over the recent years. The highest pooled prevalence was in Saudi Arabia (32.7%), and the lowest was in Kuwait (15.1%).
Purpose
To conduct a systematic review and meta-analysis on the prevalence of osteoporosis in the Eastern Mediterranean Region (EMR), as defined by the World Health Organization.
Methods
We included all observational studies reporting the prevalence of osteoporosis among general population. We searched literatures from the databases of PubMed, Scopus, Web of Science, and Index Medicus for the EMR published between January 2000 and December 2017 with no restriction of language. Two reviewers independently contributed in study selection and data extraction. STATA software was used for analyzing the collected data.
Results
A total of 1692 citations were retrieved. After excluding the irrelevant articles, 36 eligible studies were included. The overall pooled prevalence rate of osteoporosis in the EMR on 31,593 participants was 24.4% (95% confidence interval [CI], 20.4–28.4). Based on femoral densitometry, the prevalence of osteoporosis was 16.8% (95% CI, 9.5–24.2), and based on spinal densitometry, it was 24.3% (95% CI, 19.4–29.2). The pooled prevalence in males was 20.5% (95% CI, 10.5–30.5), compared with 24.4% (95% CI, 20.2–28.6) in females. The prevalence rate was significantly higher in 2007–2015 (32.7%; 95% CI, 25.1–40.3) than in 2000–2006 (19.8%; 95% CI, 12.5–27).
Conclusions
Our findings indicate a considerable prevalence of osteoporosis among the people of the EMR. The prevalence has increased during recent years, showing that osteoporosis is becoming a critical health problem in this region. Prevention and control measures need to be implemented by health service authorities.
Similar content being viewed by others
References
Ferrari S, Reginster J-Y, Brandi ML, Kanis JA, Devogelaer J-P, Kaufman J-M, Féron J-M, Kurth A, Rizzoli R (2016) Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos 11:37
Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43
Ballane G, Cauley J, Luckey M, Fuleihan GE-H (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 28:1531–1542
Cosman F, De Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381
Park K-Y, Hwang H-S, Park H-K (2017) Modifiable lifestyle factors associated with osteoporosis in Korean men: a case-control study. Arch Osteoporos 12:56
Wade S, Strader C, Fitzpatrick L, Anthony M, O’Malley C (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182
Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520–2526
Kling JM, Clarke BL, Sandhu NP (2014) Osteoporosis prevention, screening, and treatment: a review. J Women's Health (Larchmt) 23:563–572
Lewiecki EM, Wright N, Curtis J, Siris E, Gagel R, Saag K, Singer A, Steven P, Adler R (2018) Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int 29:717–722
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8:136
Cooper C, Campion G, Lr M (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Musaiger AO, Al-Hazzaa HM, Takruri HR, Mokhatar N (2012) Change in nutrition and lifestyle in the Eastern Mediterranean Region: health impact. J Nutr Metab 2012:436762
Hwalla N, Al Dhaheri AS, Radwan H, Alfawaz HA, Fouda MA, Al-Daghri NM, Zaghloul S, Blumberg JB (2017) The prevalence of micronutrient deficiencies and inadequacies in the Middle East and approaches to interventions. Nutrients 9:229
Bassil D, Rahme M, Hoteit M, Fuleihan GE-H (2013) Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5:274–298
(2015) IOF Regionals - 3rd Middle East & Africa osteoporosis meeting : plenary lecture abstracts. Osteoporos Int 26:S421-S425
The middle east & Africa Regional Audit. Epidemiology, costs & burden of osteoporosis in 2011. 2011. https://www.iofbonehealth.org/sites/default/files/PDFs/Audit%20Middle%20East_Africa/ME_audit-executive_summary.pdf
(2015) IOF Regionals - 3rd Middle East & Africa osteoporosis meeting : poster presentation abstracts. Osteoporos Int 26:S439-S486
Baddoura R, Hoteit M, Fuleihan GE-H (2011) Osteoporotic fractures, DXA, and fracture risk assessment: meeting future challenges in the eastern Mediterranean region. J Clin Densitom 14:384–394
Maalouf G, Gannagé-Yared M, Ezzedine J, Larijani B, Badawi S, Rached A, Zakroui L, Masri B, Azar E, Saba E (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 7:131–143
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
Prevalence of osteoporosis in the Eastern Mediterranean Region: a systematic review and meta-analysis. 2018. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=81807
World Health Organization. Prevention and management of osteoporosis. Geneva: WHO; 2003
2015 ISCD Official Positions – Adult. https://www.iscd.org/official-positions/2015-iscd-official-positions-adult/
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 65:934–939
Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186–191
Chen P, Li Z, Hu Y (2016) Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health 16:1039
Bayati M, Akbarian R, Kavosi Z (2013) Determinants of life expectancy in Eastern Mediterranean region: a health production function. Int J Health Policy Manag 1:57–61
Middle East & Africa Guidelines. https://www.iofbonehealth.org/middle-east-africa-guidelines
Musaiger AO, Al-Hazzaa HM (2012) Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J Gen Med 5:199–217
Irani AD, Poorolajal J, Khalilian A, Esmailnasab N, Cheraghi Z (2013) Prevalence of osteoporosis in Iran: a meta-analysis. J Res Med Sci 18:759–766
Alswat KA (2017) Gender Disparities in Osteoporosis. J Clin Med Res 9:382–387
Heidari B, Hosseini R, Javadian Y, Bijani A, Sateri MH, Nouroddini HG (2015) Factors affecting bone mineral density in postmenopausal women. Arch Osteoporos 10:15
Heidari B, Muhammadi A, Javadian Y, Bijani A, Hosseini R, Babaei M (2017) Associated factors of bone mineral density and osteoporosis in elderly males. Int J Endocrinol Metab 15:e39662
Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO (2013) Relationship between parity and bone mass in postmenopausal women according to number of parities and age. J Reprod Med 58:389–394
Hajian-Tilaki K, Heidari B (2007) Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years, in the north of Iran: a population-based study and regression approach. Obes Rev 8:3–10
Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S (2014) Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr 8:170–176
Cauley JA (2015) Estrogen and bone health in men and women. Steroids 99:11–15
Manolagas SC, O’Brien CA, Almeida M (2013) The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol 9:699–712
Zamani M, Derakhshan M, Zamani V, Shokri-Shirvani J (2018) The prevalence of Helicobacter pylori infection worldwide—knowns and unknowns. Authors’ reply. Aliment Pharmacol Ther 47:1331–1332
Acknowledgments
We are thankful to Prof. Nicola M. Lowe, Prof. Fadoua Allali, Dr. Ambreen Kazi Kamran, Dr. Naim Maalouf, Dr. Jamal Al Saleh, Dr. Sireen Shilbayeh, and Mr. Mohsen Karamati for answering our queries about their studies.
Funding
We thank the Vice Chancellor for Research and Technology of Babol University of Medical Sciences for the support on our study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Electronic supplementary material
Supplementary Table 1
(DOC 73 kb)
Supplementary Table 2
(DOC 263 kb)
Supplementary Table 3
(DOC 50 kb)
Supplementary Table 4
(DOC 52 kb)
Rights and permissions
About this article
Cite this article
Zamani, M., Zamani, V., Heidari, B. et al. Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: a systematic review and meta-analysis. Arch Osteoporos 13, 129 (2018). https://doi.org/10.1007/s11657-018-0540-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-018-0540-7